{
  "title": "Inflation, Investing, And The Latest On Omicron",
  "itunes:title": "Inflation, Investing, And The Latest On Omicron",
  "description": "<p>Sylvia Jablonski, Chief Investment Officer, Co-Founder at Defiance ETFs, discusses investing and gives her 2022 market outlook. Dr. Purvi Parikh, immunologist with the Allergy and Asthma Network, discusses the latest Omicron developments and vaccine effectiveness against the variant. Tim Fiore, Chair for the Institute for Supply Management’s (ISM) Manufacturing Business Survey Committee, discusses the ISM Semiannual Economic Forecast. Michael Cuggino, President and Portfolio Manager of the Permanent Portfolio Family of Funds, discusses investing strategies amid inflation. Hosted by Paul Sweeney and Matt Miller.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Sylvia Jablonski, Chief Investment Officer, Co-Founder at Defiance ETFs, discusses investing and gives her 2022 market outlook. Dr. Purvi Parikh, immunologist with the Allergy and Asthma Network, discusses the latest Omicron developments and vaccine effectiveness against the variant. Tim Fiore, Chair for the Institute for Supply Management’s (ISM) Manufacturing Business Survey Committee, discusses the ISM Semiannual Economic Forecast. Michael Cuggino, President and Portfolio Manager of the Permanent Portfolio Family of Funds, discusses investing strategies amid inflation. Hosted by Paul Sweeney and Matt Miller.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "8c66c8ce-5c1c-11ec-be72-378c660247bb",
  "omny:clipId": "0de842d6-84d8-46b1-b0d1-ae3c00109d4b",
  "pubDate": "Mon, 13 Dec 2021 18:51:19 +0000",
  "itunes:duration": 1557,
  "enclosure": "",
  "link": "https://omny.fm/shows/the-tape/inflation-investing-and-the-latest-on-omicron"
}